Effect of ATP-dependent channel modulators on ischemia-induced arrhythmia change depending on age and gender

Experimental Biology and Medicine

Volumn 238, Issue 10, 2013, Pages 1170-1179

  Bozdoǧan, Ömer ^a   Kaya, Salih Tunç ^b   Yaşar, Selçuk ^a   Orallar, Hayriye ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b DUZCE UNIVERSITY   (Turkey)

Author keywords

cardiac arrhythmias; coronary ligations; glybenclamide; myocardial ischemia; pinacidil; rats

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; PINACIDIL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART ARRHYTHMIA; HEART RATE; INCIDENCE; ISCHEMIA; MALE; NONHUMAN; QRS COMPLEX; RAT; ST SEGMENT ELEVATION; SURVIVAL RATE;

CARDIAC ARRHYTHMIAS; CORONARY LIGATIONS; GLYBENCLAMIDE; MYOCARDIAL ISCHEMIA; PINACIDIL; RATS;

AGE FACTORS; ANIMALS; ARRHYTHMIAS, CARDIAC; FEMALE; ISCHEMIA; KATP CHANNELS; MALE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TREATMENT OUTCOME;

EID: 84884618866     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213498980     Document Type: Article

References (29)

1. Jovanovic S,Jovanovich A.Sarcolemmal KATP channels in ageing.Ageing Res Rev. 2004;3:199-214.
2. Gonca E,Tiryaki SE,Bozdoǧan Ö.The effect of Sex on ischemia - reperfusion induced arrhythmias and the role of ATP - dependent potassium channel blockage.Turk J Biol. 2004;28:39-46.
3. Villersal RP,Woodruff AL,Massumi A.Gender and cardiac arrhythmias.Tex Heart Inst J. 2001;28:265-75.
4. Gonca E,Bozdoǧan Ö. Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against i{dotless}schemia/reperfusion-induced arrhythmia in anesthetized male rats.J Cardiovasc Pharmacol Ther. 2010;15:403-11.
5. Bozdoǧan Ö.,Gonca E,Suveren E,Gökçe F.Mechanisms of glybenclamide-mediated anti-arrhythmia and ischemic conditioning in a rat model of myocardial infarction: role of yohimbine treatment.Turk J Med Sci. 2004;34:21-8.
6. Bozdoǧan Ö.,Lepran I,Papp,JGy.Effect of the combination of glibenclamide, an ATP-dependent potassium channel blocker and metaprolol, a cardiocelective β-adrenoceptor blocker, during myocardial infarction in conscious rats.Turk J Med Sci. 2000;30:517-22.
7. Bozdogan Ö,Lepran I,Papp,JGy.Effect of glimepride and glibenclamide, inhibitors of ATP-dependent K+-channel, on ischemia-reperfusion induced arrhythmias in rats.Acta Physiol Hun. 1996;84:173-4.
8. Lepran I,Koltai M,Siegmund W,Szekeres L.Coronary artery ligations, early arrhythmias, and determinations of the ischemic area in conscious rats.J Pharmacol Method. 1983;9:219-30.
9. Walker MJA,Curtis MJ,Hearse DJ,Campbell RWF,Janse MJ,Yellon DM,Cobbe SM,Coker SJ,Harness JB,Harron DWG,Higgins AJ,Julian DG,Lab MJ,Manning AS,Northover BJ,Parratt JR,Riemersma RA,Riva E,Russell DC,Sheridan DJ,Winslow E,Woodward B.The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion.Cardiovasc Res. 1988;22:447-55.
10. Liu P,Xu B,Cavalieri TA,Hock CE.Age-related difference in myocardial function and inflammation in a rat model of myocardial ischemia-reperfusion.Cardiovasc Res. 2002;56:443-53.
11. Vajda S,Baczko I,Lepran I.Selective cardiac plasma membrane KATP channel inhibition is defibrillatory and improves survival during acute myocardial ischemia.Eur J Pharmacol. 2007;577:115-23.
12. El-Reyani NE,Bozdogan O,Baczkó I,Leprán I,Papp JG.Comparison of the efficacy of glibeclamide and glimepride in reperfusion induced arrhythmias in rats.Eur J Pharmacol. 1999;365:187-92.
13. Backo I,Lepran I,Papp GY.KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anesthetized rats.Eur J Pharmacol. 1997;324:77-83.
14. Colatsky TJ,Argentieri TM.Potassium channel blockers as antiarrhythmic drugs.Drug Develop Res. 1994;33:235-49.
15. Valle HF,Lascano EC,Negroni JA,Crottogini AJ.Glybenclamide effects on reperfusion induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep.Cardiovasc Res. 2000;150:474-85.
16. Bernauer W.Concerning the effect of the K+ channel blocking agent glybenclamide on ischemic and reperfusion arrhythmias.Eur J Pharmacol. 1997;326:147-56.
17. Das B,Sarcar C.Is the sarcolemmal or mitochondrial KATP channel activation important in the anthiarrhythmic and cardioprotective effects during acute ischemia-reperfusion in the intact anesthetized rabbit model.Life Sci. 2005;77:1226-48.
18. Lepran I,Backo I,Varró A,Papp JG.ATP sensitive potassium channel modulators; bothpinacidil and glybenclamide produce produce anthyarrhythmic activity during acute myocardial infarction in conscious rats.J Pharmacol Exp Ther. 1996;277:1215-20.
19. Fischbach PS,White A,Barrett TD,Lucchesi BR.Risk of ventricular proarrhthmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP - gated potassium channel.J Pharmacol Exp Ther. 2004;390:554-9.
20. Tosaki A,Szerdahelyi P,Engelman RM.Potassium channel openers and blockers: do they proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?.J Pharmacol Exp. 1993;263:1261-8.
21. Chi L,Uprichhard AC,Lucchesi BR.Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death.J Cardiovasc Pharmacol. 1990;15:452-64.
22. McCully JD,Toyoda Y,Wakiyama H,Rousou AJ,Parker RA,Levitsky S.Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide.Ann Thorac Surg. 2006;82:117-23.
23. Schulman D,Latchman DS,Yellon DM.Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.Am J Physiol. 2001;281:H1630-36.
24. Cole WC.ATP-sensitive K+ channels in cardiac ischemia-an endogenous mechanism for protection of the heart.Cardiovasc Drug Ther. 1993;7:527-37.
25. Carro A,Bastiaenen R,Kaski JC.Age related issues in reperfusion of myocardial infarction.Cardiovasc Drugs Ther. 2011;25:139-48.
26. Maggioni AA,Maseri A,Fresco C,Franzosi MG,Mauri F,Santoro E,Tognoni G.Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis.N Engl J Med. 1993;329:1442-8.
27. Barret CE,Bush TL.Estrogen and coronary heart disease in women.J Am Med Assoc. 1991;265:1861-7.
28. Ebert SN,Xi{dotless}ao-Ke L,Woosley RL.Gender based therapeutics. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence.J Womens Health. 1998;7:547-57.
29. Clapham JC,Trial BK,Hamilton TC.K+ channel activators, acute glucose-tolerance and glibenclamide-induced hypoglycemia in the hypertensive rat.Eur J Pharmacol. 1994;257:79-85.